Disclosures for "PAD4 Inhibitor Therapy Prevents NETs and Improves Neurological Deficits Resulting From Subarachnoid Hemorrhage"
-
Mr. Samal has nothing to disclose.
-
Dr. Hong has nothing to disclose.
-
Dr. Dienel has nothing to disclose.
-
The institution of Prof. McBride has received research support from APT Therapeutics, INC. Prof. McBride has received intellectual property interests from a discovery or technology relating to health care. Prof. McBride has received personal compensation in the range of $0-$499 for serving as a Grand Rounds Presenter with Barrow Neurological Institute.